RESOURCE CENTER

Scientific Journal
Shortening Drug Development Timelines with Asian Ethnobridging Trials
A Phase I ethnobridging strategy allows you to recruit patients in “global” safety and efficacy trials (Phases II and III) without repeating Phase I development in that region and population.